Preparation and cytocompatibility of a novel bismuth aluminate/calcium phosphate cement with high radiopacity.

Author(s) Wu, T.; Yang, S.; Shi, H.; Ye, J.
Journal J Mater Sci Mater Med
Date Published 2018 Sep 04

In a minimally invasive surgery, using a bone cement being radiologically detectable is vital to the success of the procedure and avoiding cement leakage in the early stage. The radiopacity of calcium phosphate cement (CPC) is inadequate, thus limiting its clinic application in this area. In this work, bismuth aluminate (BiA) was employed as a radiopaque agent for CPC. The influences of BiA on physicochemical, radiopaque and in vitro biocompatible properties of CPC were investigated. With the increasing content of BiA, the setting time and the compressive strength of CPC were augmented, while the injectability of the cement pastes was reduced. The radiopacity of CPC was significantly improved by adding more than 6 wt.% BiA. CPC specimens with less than 12 wt.% BiA showed good cellular affinity. Moreover, the CPC containing 6 and 9 wt.% BiA promoted the cell growth and ALP activity of mouse bone marrow mesenchymal stem cells when compared with the control. On the basis of its improved radiopacity and cytocompatibility, the radiopaque CPC with 6 ~ 9 wt.% BiA is expected to be a potential substitute for bone defect restoration via minimally invasive surgery. CPC with bismuth aluminate reveals better radiopacity and cell affinity along with proper physicochemical properties.

DOI 10.1007/s10856-018-6154-1
Keywords Alkaline Phosphatase; Aluminum; Animals; Bismuth; Bone Cements; Calcium Phosphates; Cell Adhesion; Cell Proliferation; Cells, Cultured; Materials Testing; Mesenchymal Stem Cells; Mice
ISSN 1573-4838
Citation J Mater Sci Mater Med. 2018;29(9):149.

Related Applications, Forms & Industries